Objective: To describe the epidemiological, clinical, therapeutic and prognostic aspects of breast cancer in women aged 40 years and younger. Material and methods: This was are retrospective descriptive cohort of 128 months, from April 11, 2007, to December 31, 2017; including patients aged 40 years and younger who had been treated and followed up for breast cancer at the surgical oncology unit of the Donka CHU National Hospital in Conakry. Results: A total of 184 patients were enrolled in this study. The mean age was 33.5 ± 5.4 years. A family history of breast cancer was found in 16 (8.69%) patients. The presence of nodule was the most frequent symptom (91.3%). It was an infiltrating ductal carcinoma in 67.3% of patients. Stages IIIB, IV, and IIIA were the most frequent with 40.2%, 23.3% and 9.2% respectively. Mastectomy was radical in 93.9% of the cases. The associated treatments were chemotherapy (86.4%), radiotherapy (15.7%) and hormone therapy (2.7%). We recorded 79 (42.9%) deaths. Overall survival at 5 years was 31%. Conclusion: Breast cancer in young women remains serious because of its high frequency, more progressive form, and poorer prognosis compared with that of older patients.
| Published in | Cancer Research Journal (Volume 11, Issue 3) |
| DOI | 10.11648/j.crj.20231103.16 |
| Page(s) | 116-121 |
| Creative Commons |
This is an Open Access article, distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution and reproduction in any medium or format, provided the original work is properly cited. |
| Copyright |
Copyright © The Author(s), 2023. Published by Science Publishing Group |
Breast Cancer, Young Women, Conakry
| [1] | Bray F, Ferlay J, Soerjomataram I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 2018; 68: 394-424. https://doi.org/10.3322/caac.21492 |
| [2] | Bollet MA, Sigal-Zafrani B, Mazeau V, et al. Corrigendum to "Age remains the first prognostic factor for locoregional breast cancer recurrence in young (<40 years) women treated with breast cancer conserving surgery first". Radiother Oncol 2007; 82: 272-80. |
| [3] | Coulombe G, Tyldesley S, Speers C, et al. Is mastectomy superior to breast-conserving treatment for young women? Int J Radiat Oncol Biol Phys 2007; 67: 1282-90. |
| [4] | Ndounga E, Bambara AT, Bolenga Liboko AF, et al. Breast cancer in women aged 35 and under at Brazzaville University Hospital. PAMJ Clin Med 2020; 2. https://www.clinical-medicine.panafrican-med-journal.com/content/article/2/94/full |
| [5] | Fidler MM, Gupta S, Soerjomataram I, et al. Cancer incidence and mortality among young adults aged 20-39 years worldwide in 2012: a population-based study. Lancet Oncol 2017; 18: 1579-89. https://doi.org/10.1016/s1470-2045(17)30677-0 |
| [6] | Lanta Q, Arveux P, Asselain B. Epidemiology and socio-cultural specificities of young women with breast cancer. Bull Cancer 2019; 106: S4-9. https://doi.org/10.1016/s0007-4551 (20)30041-2 |
| [7] | Vanderpuye V, Grover S, Hammad N, et al. An update on the management of breast cancer in Africa. Infect Agent Cancer 2017; 12. https://doi.org/10.1186/s13027-017-0124-y |
| [8] | Fleurier C, Pilloy J, Chas M, et al. Breast cancer in patients under 40 years of age: presentation and evolutionary characteristics. Gynécol Obstétr Fertil Sénol 2018; 46: 105-11. https://doi.org/10.1016/j.gofs.2017.12.012 |
| [9] | André C, Collignon J, Rorive A, et al. Breast cancer in young women. Rev Med Liège 2011; 66: 397-9. PMID: 21826983. |
| [10] | Benbakhta B, Tazi M, Benjaafar N, et al. Determinants of patient delays and health system of women with breast cancer in Morocco, 2013. Rev d'épidémiologie Santé Publique 2015; 63: 191-201. https://doi.org/10.1016/j.respe.2015.03.121 |
| [11] | Aloulou S, El Mahfoudi A, El Omrani A, Khouchani M. Factors related to late diagnosis of breast cancer: experience of CHU Mohammed VI Marrakech. Pan Afr Med J 2015; 21. https://doi.org/10.11604/pamj.2015.21.162.4363 |
| [12] | Gabriel CA, Domchek SM. Breast cancer in young women. Breast Cancer Res BCR 2010; 12: 212. https://doi.org/10.1186/bcr2647 |
| [13] | Mathew G and Agha R, for the STROCSS Group. STROCSS 2021: Strengthening the Reporting of cohort, cross-sectional and case-control studies in Surgery. International Journal of Surgery 2021; 96: 106165 |
| [14] | Gueye M, Kane Gueye SM, Ndiaye Gueye MD, et al. Breast cancer in women younger than 35 years: features and outcomes in the breast unit at Aristide le Dantec Teaching Hospital, Dakar. Médecine Santé Trop 2016; 26: 377-81. https://doi.org/10.1684/mst.2016.0637 |
| [15] | Anders CK, Johnson R, Litton J, et al. Breast Cancer Before Age 40 Years. Semin Oncol 2009; 36: 237-49. https://doi.org/10.1053/j.seminoncol.2009.03.001 |
| [16] | Han W, Kim SW, Ae Park I, et al. Young age: an independent risk factor for disease-free survival in women with operable breast cancer. BMC Cancer 2004; 4: 82. https://doi.org/10.1186/1471-2407-4-82 |
| [17] | Arnould L, Penault-Llorca F, Dohollou N, et al. Breast cancer in young women. Histological and prognostic specificities: how do they differ from older women? Bull Cancer 2019; 106: S10-8. doi: 10.1016/S0007-4551(20)30042-4. |
| [18] | Merviel P, Jouvance O, Naepels P, et al. Are there still risk factors for breast cancer? Gynécol Obstétr Fertil 2011; 39: 486-90. https://doi.org/10.1016/j.gyobfe.2010.10.015 |
| [19] | Guendouz H, Chetibi W, Abdelouahab A, Bendib A. Breast cancer in women under 35 years of age: a retrospective study of 612 cases. Lett Sénologue 2011: 28–31. http://ao.um5.ac.ma/xmlui/bitstream/handle/123456789/15019/M0672016.pdf?sequence=1&isAllowed=y |
| [20] | Boudaoud K, Benahcene A, Sahli M, Djemaa A. Management of breast cancer in young women in the radiotherapy oncology department of the university hospital of Constantine. Cancer/Radiothérapie 2011; 15: 578–9. doi: 10.1016/j.jradio.2014.03.011. |
APA Style
Malick Bah, Keita Mamady, Touré Alhassane Ismael, Cisse Kalil, Souare Mamadou Bobo, et al. (2023). Breast Cancer in Women Under 40 Years of Age Surgical Oncology Unit of Donka National Hospital a Retrospective Cohort Study. Cancer Research Journal, 11(3), 116-121. https://doi.org/10.11648/j.crj.20231103.16
ACS Style
Malick Bah; Keita Mamady; Touré Alhassane Ismael; Cisse Kalil; Souare Mamadou Bobo, et al. Breast Cancer in Women Under 40 Years of Age Surgical Oncology Unit of Donka National Hospital a Retrospective Cohort Study. Cancer Res. J. 2023, 11(3), 116-121. doi: 10.11648/j.crj.20231103.16
AMA Style
Malick Bah, Keita Mamady, Touré Alhassane Ismael, Cisse Kalil, Souare Mamadou Bobo, et al. Breast Cancer in Women Under 40 Years of Age Surgical Oncology Unit of Donka National Hospital a Retrospective Cohort Study. Cancer Res J. 2023;11(3):116-121. doi: 10.11648/j.crj.20231103.16
Share This Article
Twitter
Linked In
Facebook
Copy
Download@article{10.11648/j.crj.20231103.16,
author = {Malick Bah and Keita Mamady and Touré Alhassane Ismael and Cisse Kalil and Souare Mamadou Bobo and Conde Ibrahima Kalil and Traore Bangaly},
title = {Breast Cancer in Women Under 40 Years of Age Surgical Oncology Unit of Donka National Hospital a Retrospective Cohort Study},
journal = {Cancer Research Journal},
volume = {11},
number = {3},
pages = {116-121},
doi = {10.11648/j.crj.20231103.16},
url = {https://doi.org/10.11648/j.crj.20231103.16},
eprint = {https://article.sciencepublishinggroup.com/pdf/10.11648.j.crj.20231103.16},
abstract = {Objective: To describe the epidemiological, clinical, therapeutic and prognostic aspects of breast cancer in women aged 40 years and younger. Material and methods: This was are retrospective descriptive cohort of 128 months, from April 11, 2007, to December 31, 2017; including patients aged 40 years and younger who had been treated and followed up for breast cancer at the surgical oncology unit of the Donka CHU National Hospital in Conakry. Results: A total of 184 patients were enrolled in this study. The mean age was 33.5 ± 5.4 years. A family history of breast cancer was found in 16 (8.69%) patients. The presence of nodule was the most frequent symptom (91.3%). It was an infiltrating ductal carcinoma in 67.3% of patients. Stages IIIB, IV, and IIIA were the most frequent with 40.2%, 23.3% and 9.2% respectively. Mastectomy was radical in 93.9% of the cases. The associated treatments were chemotherapy (86.4%), radiotherapy (15.7%) and hormone therapy (2.7%). We recorded 79 (42.9%) deaths. Overall survival at 5 years was 31%. Conclusion: Breast cancer in young women remains serious because of its high frequency, more progressive form, and poorer prognosis compared with that of older patients.},
year = {2023}
}
TY - JOUR T1 - Breast Cancer in Women Under 40 Years of Age Surgical Oncology Unit of Donka National Hospital a Retrospective Cohort Study AU - Malick Bah AU - Keita Mamady AU - Touré Alhassane Ismael AU - Cisse Kalil AU - Souare Mamadou Bobo AU - Conde Ibrahima Kalil AU - Traore Bangaly Y1 - 2023/09/27 PY - 2023 N1 - https://doi.org/10.11648/j.crj.20231103.16 DO - 10.11648/j.crj.20231103.16 T2 - Cancer Research Journal JF - Cancer Research Journal JO - Cancer Research Journal SP - 116 EP - 121 PB - Science Publishing Group SN - 2330-8214 UR - https://doi.org/10.11648/j.crj.20231103.16 AB - Objective: To describe the epidemiological, clinical, therapeutic and prognostic aspects of breast cancer in women aged 40 years and younger. Material and methods: This was are retrospective descriptive cohort of 128 months, from April 11, 2007, to December 31, 2017; including patients aged 40 years and younger who had been treated and followed up for breast cancer at the surgical oncology unit of the Donka CHU National Hospital in Conakry. Results: A total of 184 patients were enrolled in this study. The mean age was 33.5 ± 5.4 years. A family history of breast cancer was found in 16 (8.69%) patients. The presence of nodule was the most frequent symptom (91.3%). It was an infiltrating ductal carcinoma in 67.3% of patients. Stages IIIB, IV, and IIIA were the most frequent with 40.2%, 23.3% and 9.2% respectively. Mastectomy was radical in 93.9% of the cases. The associated treatments were chemotherapy (86.4%), radiotherapy (15.7%) and hormone therapy (2.7%). We recorded 79 (42.9%) deaths. Overall survival at 5 years was 31%. Conclusion: Breast cancer in young women remains serious because of its high frequency, more progressive form, and poorer prognosis compared with that of older patients. VL - 11 IS - 3 ER -
Email: